ARCHIVES

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

This article is from The Cancer Letter archive.

Vol. 01 No. 38 | September 19, 1975

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 10 Issue 3, Winter 1996

January 13, 1996

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

March 26, 2010

Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement

July 25, 2013

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989